Turanabol by Balkan Pharmaceuticals delivers 4-chlorodehydromethyltestosterone, an orally bioavailable derivative of methandrostenolone (Dianabol) modified by a 4-chloro substitution. This molecular alteration completely prevents aromatization into estrogenic metabolites, eliminating common issues such as gynecomastia, hypertension, and fluid retention. Athletes seeking lean vascular gains, improved muscular endurance, and recovery rely on Turinabol as a cornerstone oral agent.
By binding to androgen receptors with moderate affinity while strongly binding to sex hormone-binding globulin (SHBG), Turanabol liberates higher concentrations of circulating free testosterone. This potentiates any concurrent anabolic compounds in a cycle, enhancing overall nitrogen retention, cellular protein synthesis, and red blood cell production without excessive weight spikes.
Due to its 16-hour active half-life, daily dosing is standard. Splitting the daily allowance into morning and evening doses maintains stable plasma concentrations:
Turanabol exhibits 17-alpha-alkylation, meaning liver support (such as TUDCA or NAC) and routine liver enzyme monitoring are advised throughout the cycle.
Turanabol pairs effectively with injectable androgens such as Testosterone Enanthate, Primobolan, or Boldenone. Its SHBG-lowering properties maximize the anabolic response of stacked compounds. Following cycle completion, an endogenous testosterone protocol (PCT) using Clomiphene Citrate (Clomid) or Tamoxifen (Nolvadex) is necessary to restore hypothalamic-pituitary-gonadal (HPG) axis balance.
No. Turanabol cannot aromatize into estrogen, meaning users do not experience fluid retention, bloating, or estrogen-induced gynecomastia during a standard cycle.
A standard cycle ranges between 6 and 8 weeks. Exceeding 8 weeks is discouraged due to potential hepatic strain and temporary lipid profile shifts.
Yes. Even though Turanabol is a mild oral androgen, it suppresses endogenous testosterone production. A 3 to 4-week PCT ensures rapid endocrine recovery.
